Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Elevance Health's accounts receivables for the quarter that ended in Jun. 2026 was MXN191,782 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Elevance Health's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 19.87.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Elevance Health's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was MXN-3,006.39.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Elevance Health's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Elevance Health's accounts receivable are only considered to be worth 75% of book value:
Elevance Health's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Elevance Health Accounts Receivable Related Terms
Elevance Health Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Elevance Health's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Accounts Receivable of MXN191,782 Mil mean?
Elevance Health (MEX:ELV) has a Accounts Receivable of MXN191,782 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Elevance Health and its competitors.
Is Elevance Health's Accounts Receivable too high?
Elevance Health's current Accounts Receivable is MXN191,782 Mil. Overall, Elevance Health has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Accounts Receivable compare to CI and CVS?
Elevance Health's Accounts Receivable of MXN191,782 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Plans company?
A good Accounts Receivable depends on the Healthcare Plans industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Elevance Health and its competitors. Elevance Health's current Accounts Receivable is MXN191,782 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Elevance Health (MEX:ELV) has a current Accounts Receivable of MXN191,782 Mil. The stock's GF Value™ is MXN7,444.87, compared to a current price of MXN6,449.00 — trading 13.4% below its estimated fair value. The current Accounts Receivable is MXN191,782 Mil. Elevance Health's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current Accounts Receivable is MXN191,782 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (MEX:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of MXN6,449.00 is trading 13.4% below its estimated GF Value™ of MXN7,444.87.
Key valuation signals for MEX:ELV:
Accounts Receivable: MXN191,782 Mil
GF Value™: MXN7,444.87 vs. price of MXN6,449.00 (13.4% below fair value)
No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
90GF Score
Get the complete analysis for MEX:ELV
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELV has been successfully added to your 
